Description:
BiomX Inc., a clinical-stage microbiome company, develops products using natural and man-made phage technologies designed to target and kill specific harmful bacteria. The company is headquartered in Ness Ziona, Israel.
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address:
17 STATE STREET, 16TH FLOOR, NEW YORK, NY, US
Fiscal year end:
December
Market capitalization:
$12.3 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
6 years:
-99%
How much will you get:
$6
Prices dates:
13-03-2019: $96.50 and 31-03-2025: $0.56